The most probable number (MPN) bioburden test method can be a valuable tool for determining bioburden counts when the typical bioburden test methods are problematic on a particular product or when a ...
Bioburden testing serves a variety of purposes, and the relevance of the data can range from relatively insignificant to extremely critical. Bioburden tests can be used for general tracking or ...
The Global Bioburden Testing Market has experienced consistent growth, with a compound annual growth rate (CAGR) of 12-15%. This growth is driven by tightening regulatory standards and an increasing ...
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Bioburden Testing Market Size, Share and Trends Analysis Report by Product (Consumables, Instruments), Test, Application, End-use, and Region 2024-2030" ...
As biopharma companies fine-tune their strategies for continuous bioprocessing, bioburden control has become a top priority. The approaches that worked for batch processing are inadequate for ...
According to the latest research by Fact.MR., the bioburden testing market is set to witness rapid growth during the forecast period (2021-2031). Rising safety concernss and an increase in number rate ...
Richmond, Feb. 23, 2024 (GLOBE NEWSWIRE) -- According to MarketDigits, the Bioburden Testing Market was valued USD 1.2 Billion in 2023 and projected to reach USD 2.8 Billion by 2030, growing at a CAGR ...
This in vitro model was designed to determine whether using a no-touch method for catheter preparation and insertion would affect the degree of contamination transmitted to intermittent urinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results